Your browser doesn't support javascript.
loading
The Effect of Dose Escalation on the Cost-Effectiveness of Etanercept and Adalimumab with Methotrexate Among Patients with Moderate to Severe Rheumatoid Arthritis.
Incerti, Devin; Hernandez, Ervant J Maksabedian; Tkacz, Joseph; Jansen, Jeroen P; Collier, David; Gharaibeh, Mahdi; Moore-Schiltz, Laura; Stolshek, Bradley S.
Afiliación
  • Incerti D; Precision Health Economics, Oakland, California.
  • Hernandez EJM; Amgen, Thousand Oaks, California.
  • Tkacz J; IBM Watson Health, Cambridge, Massachusetts.
  • Jansen JP; Precision Health Economics, Oakland, California.
  • Collier D; Amgen, Thousand Oaks, California.
  • Gharaibeh M; Amgen, Thousand Oaks, California.
  • Moore-Schiltz L; IBM Watson Health, Cambridge, Massachusetts.
  • Stolshek BS; Amgen, Thousand Oaks, California.
J Manag Care Spec Pharm ; 26(10): 1236-1242, 2020 Oct.
Article en En | MEDLINE | ID: mdl-32996384
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Artritis Reumatoide / Metotrexato / Adalimumab / Etanercept Tipo de estudio: Health_economic_evaluation / Prognostic_studies Límite: Adult / Female / Humans / Male / Middle aged País/Región como asunto: America do norte Idioma: En Revista: J Manag Care Spec Pharm Año: 2020 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Artritis Reumatoide / Metotrexato / Adalimumab / Etanercept Tipo de estudio: Health_economic_evaluation / Prognostic_studies Límite: Adult / Female / Humans / Male / Middle aged País/Región como asunto: America do norte Idioma: En Revista: J Manag Care Spec Pharm Año: 2020 Tipo del documento: Article